Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boric Acid vs Povidone Iodine in Otomycosis
NCT07295210Completed
- Sponsor
- Mansoura University
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised trial in otomycosis comparing Boric acid group with Povidone iodine group (2 arms). Primary endpoints: Objective clinical response at 28 days and Microbiological response at 28 days. Started Dec 2024; status: completed.
02
Drugs
boric acidpovidone-iodine
03
Conditions
otomycosis
Beyond the preview
Go deeper on NCT07295210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07295210.